Oregon Cancer

News and information for cancer services throughout Oregon.

  • Harnessing CAR T-cell therapy: A new study for indolent B-cell non-Hodgkin lymphoma

    Harnessing CAR T-cell therapy: A new study for indolent B-cell non-Hodgkin lymphoma

    New study evaluates a type of CAR T-cell therapy called liso-cel. Researchers will collect data from multiple groups in a study that may give patients hope for long-term remission and quality of life.

    Read Article
  • New studies test immunotherapy to boost breast cancer treatment and prevent return

    New studies test immunotherapy to boost breast cancer treatment and prevent return

    Explore promising clinical trials at Providence Cancer Institute that are investigating immunotherapy for early-stage TNBC and high-risk, HR-positive breast cancer.

    Read Article
  • Attend a free virtual symposium on melanoma, Oct. 25

    Attend a free virtual symposium on melanoma, Oct. 25

    Providence Cancer Institute in partnership with AIM at Melanoma present a free online event designed to educate and empower patients and care partners affected by melanoma.

    Read Article
  • Prostate cancer study includes a tumor test to personalize treatment

    Prostate cancer study includes a tumor test to personalize treatment

    A new study approach reflects a deeper understanding of cancer at the molecular level and marks a shift away from one-size-fits-all treatments.

    Read Article
  • Meet physician scientist, Dr. Allie Grossmann

    Meet physician scientist, Dr. Allie Grossmann

    Dr. Allie Grossmann’s new lab at Earle A. Chiles Research Institute is focused on understanding how tumors communicate with their environment, grow, survive and spread.

    Read Article
  • Dr. Walter Urba announces retirement from Providence

    Dr. Walter Urba announces retirement from Providence

    Dr. Walter Urba, a pioneer and key figure in the development of immunotherapy, will retire from Providence Cancer Institute at the end of year.

    Read Article
  • Dr. Bernard Fox honored for his lifetime contributions to cancer research

    Dr. Bernard Fox honored for his lifetime contributions to cancer research

    Prominent cancer scientist Dr. Bernard Fox recognized for his work to advance the field of cancer immunotherapy through increasing public understanding, awareness and research efforts.

    Read Article
  • Can these new studies offer hope for people with lung and head and neck cancers?

    Can these new studies offer hope for people with lung and head and neck cancers?

    A new medication may help people with KRAS G12C-mutant non-small cell lung cancer. Read about the study and a trial evaluating an immunotherapy for treating head and neck squamous cell carcinoma.

    Read Article
  • Cancer survivor speaks with doctor he credits for saving his life

    Cancer survivor speaks with doctor he credits for saving his life

    Cancer survivor Mark Williams chats with Dr. Brendan Curti about

    Read Article
  • 2024 Hood to Coast Relay: Providence team captains tell us why they run

    2024 Hood to Coast Relay: Providence team captains tell us why they run

    What motivates the co-captains of the FINISHCANCER caregiver team to commit their time to running this remarkable relay? Read what they say about preparing for the race and what inspires them to run.

    Read Article
  • Promising advances in treating TNBC: Two studies offer hope

    Promising advances in treating TNBC: Two studies offer hope

    Although chemotherapy is the cornerstone treatment for triple negative breast cancer, survival outcomes remain disappointing. Two studies could help improve treatment options.

    Read Article
  • Targeting cancer cells: Two studies take different approaches

    Targeting cancer cells: Two studies take different approaches

    A study designed to treat recurrent epithelial ovarian cancer looks at an antibody drug conjugate, and a second study for people with advanced breast cancer evaluates a drug that degrades estrogen rec

    Read Article
  • The evolution of cancer immunotherapy: Dr. Urba shares his insights

    The evolution of cancer immunotherapy: Dr. Urba shares his insights

    Providence Cancer Institute chief medical officer Walter J. Urba, M.D., Ph.D. talks about the evolution of immunotherapy in the past three decades and his vision for its future.

    Read Article
  • Cancer survivorship: A guide to living with and beyond cancer

    Cancer survivorship: A guide to living with and beyond cancer

    June is National Cancer Survivor Month, but we honor people with cancer, no matter where they are on their journey, every day of the year. Find out about the survivorship program at Providence Cancer

    Read Article
  • Radiation oncologist discusses MRI-guided radiation therapy for pancreatic cancer

    Radiation oncologist discusses MRI-guided radiation therapy for pancreatic cancer

    Providence Cancer Institute presented a free virtual education event about MRI-guided radiation therapy and how it is used to treat pancreatic cancer.

    Read Article
  • Providence researchers contribute study findings at ASCO 2024 meeting, May 31- June 3

    Providence researchers contribute study findings at ASCO 2024 meeting, May 31- June 3

    The annual meeting of cancer experts is a platform to collaborate and accelerate cancer research findings into clinical applications.

    Read Article
  • With the potential to transform cancer diagnostics, Providence contributes to innovative AI-powered digital pathology model

    With the potential to transform cancer diagnostics, Providence contributes to innovative AI-powered digital pathology model

    A joint study between Providence, Microsoft and the University of Washington detailing work to create a novel AI-powered pathology model has been published in Nature.

    Read Article
  • 2023 research report highlights breadth and impact of research at Providence

    2023 research report highlights breadth and impact of research at Providence

    Providence researchers conducted over 2400 studies in 2023, according to the 2023 Providence Research Network Annual Report

    Read Article
  • Cancer studies seek to harness the power of the immune system

    Cancer studies seek to harness the power of the immune system

    Explore three innovative studies targeting uveal melanoma, melanoma and head and neck squamous cell carcinoma. Learn why these studies offer hope for more effective cancer treatments.

    Read Article
  • Celebrating World Immunology Day

    Celebrating World Immunology Day

    Providence Cancer Institute researcher shares her journey to immunology and the advice she has for those seeking a career in cancer research.

    Read Article
  • loading
    Loading More...